Prevention of retinopathy of prematurity

João Borges Fortes Filho1, Gabriela Unchalo Eckert, Marcia Beatriz Tartarella

  • 1Department of Ophthalmology, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Brazil. jbfortes@prorop.com.br

Insights

Retinopathy of prematurity (ROP) is a serious eye condition in premature infants. This article reviews key preventive strategies to reduce ROP incidence and severity.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Vascular Biology

Background:

  • Retinopathy of prematurity (ROP) is a leading cause of preventable blindness in preterm infants.
  • ROP pathogenesis involves oxygen-regulated growth factors (VEGF, IGF-I) and abnormal retinal vascular development.
  • Increased preterm infant survival rates correlate with a rising global prevalence of ROP, particularly in developing regions.

Purpose of the Study:

  • To outline the primary preventive measures for retinopathy of prematurity.
  • To highlight the importance of early diagnosis and intervention in managing ROP.
  • To discuss the impact of supplemental oxygen on retinal vasculogenesis and ROP onset.

Main Methods:

  • Review of existing literature on ROP pathogenesis and prevention.
  • Analysis of factors contributing to increased ROP prevalence in preterm infants.
  • Synthesis of current recommendations for ROP management.

Main Results:

  • Supplemental oxygen can cause retinal hyperoxia, vasoconstriction, and interrupted vasculogenesis.
  • Peripheral retinal ischemia is a key factor stimulating neovascularization and ROP complications.
  • Prompt diagnosis and management are crucial to prevent irreversible blindness.

Conclusions:

  • Effective ROP prevention strategies are essential for safeguarding vision in preterm infants.
  • Understanding the role of oxygen and growth factors is key to developing targeted interventions.
  • Global collaboration is needed to address the increasing burden of ROP in emerging economies.